Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Will have to adjust resolve date based on when CDC releases the data. If the rate decreases while all the products are pulled from market, or not sold in a reasonable quantity, it won't count.

Get Ṁ600 play money
Sort by:

I assume this resolves positively based entirely on obesity rates in the US, is that correct? I guess if GLP-1 Agonists are entirely pulled from the market it will resolve negatively regardless of obesity rates?

bought Ṁ20 of YES

Obesity rates have already been falling in children, teens, and very young adults iirc. We're already past an inflection point.

More related questions